0001213900-24-044315.txt : 20240516 0001213900-24-044315.hdr.sgml : 20240516 20240516161052 ACCESSION NUMBER: 0001213900-24-044315 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tesi Raymond Joseph CENTRAL INDEX KEY: 0001767280 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 24955644 MAIL ADDRESS: STREET 1: 476 MASSACHUSETTS AVE, UNIT 2 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 NE MIZNER BLVD, SUITE 640 CITY: BOCA RATON STATE: FL ZIP: 33432 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 225 NE MIZNER BLVD, SUITE 640 CITY: BOCA RATON STATE: FL ZIP: 33432 4 1 ownership.xml X0508 4 2024-05-14 0 0001711754 Inmune Bio, Inc. INMB 0001767280 Tesi Raymond Joseph C/O INMUNE BIO INC. 225 NE MIZNER BLVD., SUITE 640 BOCA RATON, FL 33432 1 1 1 0 President and CEO 0 Option (right to buy) 9.92 2024-05-14 4 A 0 160000 0 A 2034-05-13 Common Stock 160000 160000 D Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date. /s/ Raymond Joseph Tesi 2024-05-16